- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Claritev Corporation(CTEV)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CTEV
11/13/2026: CTEV (1-star) is currently NOT-A-BUY. Pass it for now.
Claritev Corporation is a healthcare technology and data analytics company that provides payment integrity, cost management, and network solutions to U.S. health insurers. The company's main strengths lie in its deeply embedded payer relationships and historically high operating margins. Its primary investment story centers on growth opportunities in healthcare pricing transparency tools and digital cost-containment. However, key risks include heavy debt leverage, customer concentration, and ongoing regulatory and legal scrutiny regarding its pricing methodologies. The stock may best suit growth or value investors willing to tolerate high volatility, while market participants should closely monitor debt reduction progress and regulatory developments.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Moderate revenue expansion and digital healthcare product launches offer growth angles, but overall top-line acceleration is gradual. |
| Momentum investor | Strong fit while signal remains positive | Momentum fit is conditional on a positive Upturn signal and supportive short-term price trend breakouts. |
| Value investor | Mixed fit | Low valuation multiples appeal to deep-value mandates, but leverage and regulatory risks warrant careful fundamental screening. |
| Dividend investor | Weak fit | The company does not pay regular dividends, focusing cash flow instead on debt management. |
| Low-risk investor | Weak fit | High equity volatility and regulatory headlines create too much operational risk for risk-averse strategies. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock experiences sharp price swings driven by market sentiment, earnings updates, and legal headlines. |
| Valuation risk | Medium / high | Market pricing reflects skepticism regarding leverage and regulatory headwinds, increasing sensitivity to execution missteps. |
| Competition risk (AI and healthcare IT competition) | Medium | In-house payer solutions and competing data analytics firms pressure pricing power and contract retention. |
| Business quality | Medium | While core margins are historically strong, enterprise concentration introduces structural vulnerability. |
| Dividend income | Low / none | Income-focused investors receive no regular cash payout from the stock. |
| Execution risk | Medium / high | Successfully scaling new transparency tools while managing legacy debt requires flawless operational execution. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 457.95M USD | Price to earnings Ratio - | 1Y Target Price 48.6 |
Price to earnings Ratio - | 1Y Target Price 48.6 | ||
Volume (30-day avg) 268.0K shares | Beta 1.05 | 52 Weeks Range 11.50 - 55.50 | Updated Date 11/15/2026 |
52 Weeks Range 11.50 - 55.50 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -16.41 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Health Information Services
- BUY participation
- 100.0%
- Active BUY / eligible
- 4 / 4
- 30-Day BUY Count Change
- +2
Eligible universe: 4 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -49.13% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Claims Intelligence & Network Services | Fees and transaction-based revenues generated from reference-based pricing, out-of-network negotiations, and proprietary provider network access. | Claritev earns money every time health plans use its networks and pricing tools to lower medical claim payouts. |
| Payment and Revenue Integrity | Pre- and post-payment review services, clinical editing, and coding analytics designed to recover improper medical billing. | The company captures a portion of the healthcare savings it uncovers by catching billing errors for insurers. |
| Data & Analytics Solutions | Subscription-based intelligence software, risk scoring models, and decision-support platforms like PlanOptix and BenInsights. | Insurers and employers pay recurring software and data fees to access Claritev's healthcare cost analytics. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 3.66 | Enterprise Value 5.18B | Price to Sales(TTM) 0.45 |
Enterprise Value 5.18B | Price to Sales(TTM) 0.45 | ||
Enterprise Value to Revenue 5.09 | Enterprise Value to EBITDA 10.55 | Shares Outstanding 17.07M | Shares Floating 6.84M |
Shares Outstanding 17.07M | Shares Floating 6.84M | ||
Percent Insiders 7.57 | Percent Institutions 88.47 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

